The insertion process is quick (typically 15-30 minutes), requires little downtime, and is performed under local anesthetic
Current findings are derived primarily from preclinical and experimental research settings
To ensure that findings are generalizable, key next steps will be to replicate and extend this work with variations of the target (e.g., gender, race/ethnicity, prior attempts at weight loss, cost paid for medication) and diverse groups of participants, both in terms of participant demographics and preexisting knowledge of GLP-1s (e.g., general population, eligible patients, healthcare professionals)
Treatment usually begins with a low dose, which can later be adjusted by a doctor to balance effectiveness and tolerability
Emerging evidence indicates that certain probiotic strains can potently induce the expansion and enhance the functional activity of regulatory T cells